Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitors
申请人:Eli Lilly and Company
公开号:US07037932B2
公开(公告)日:2006-05-02
There is provided a heretoaryloxy 3-substituted propanamine compound of formula (I): wherein A is selected from —O— and —S—; X is selected from phenyl optionally substituted with up to 5 substituents selected from halo, C1–C4 alkyl and C1–C4 alkoxy, and thienyl optionally substituted with up to 3 substituents selected from halo and C1–C4 alkyl; Y is selected from benzothienyl, indolyl and benzofuranyl, optionally substituted with up to 5 substituents selected from halo, C1–C4 alkyl, C1–C4 alkoxy, nitro, acetyl and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1–C4 alkyl; R1 and R2 are each independently H or C1–C4 alkyl; and pharmaceutically acceptable salts thereof.
提供了一种公式(I)的取代了3-丙胺基的芳氧烷基化合物,其中A选自-O-和-S-; X选自苯基,可选地取代最多5个卤素,C1-C4烷基和C1-C4烷氧基,和噻吩基,可选地取代最多3个卤素和C1-C4烷基; Y选自苯并噻吩基,吲哚基和苯并呋喃基,可选地取代最多5个卤素,C1-C4烷基,C1-C4烷氧基,硝基,乙酰基和氰基; 当Y为吲哚基时,它可以被一个选自C1-C4烷基的N-取代基所取代或进一步取代; R1和R2各自独立地选自H或C1-C4烷基;以及其药学上可接受的盐。